Pulse Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Pulse Biosciences

11/05/2021 24:43

* Pulse Biosciences Inc  PLSE.OQ  reported a quarterly adjusted
loss of 71 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 49 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Pulse Biosciences Inc's reported EPS for the quarter was a
loss of 71 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Pulse Biosciences Inc shares had fallen by 27.6% this
quarter and lost 28.1% so far this year.
* The company reported a quarterly loss of $18.64 million.
* Wall Street's median 12-month price target for Pulse
Biosciences Inc is $43.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 10 at 11:43 p.m. GMT.
​All figures in $